Omaxe Ltd
Omaxe Q2 FY17 earnings call: Revenue & Margins
Q2 FY17 investor presentation: what the company reported on revenue, margins and projects.
Based on Omaxe Ltd's Q2 FY17 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q2 FY17 vs Q2 FY16 Sales/Volume: - Area Sold: 0.79 mn sq.ft (Q2 FY17) vs 1.24 mn sq.ft (Q2 FY16), down 36% - Value of Booking: Rs. Q2 FY17 Financials vs Q2 FY16: - EBITDA: ₹90 crore (up from ₹68 crore) - PAT: ₹23 crore (up from ₹12 crore) - Operating (EBITDA) margin = EBITDA / Turnover = 90 / 327 ≈ 27.5% (Q2 FY16 margin = 68 / 301 ≈ 22.6%) - Year-on-Year Change: - EBITDA increased by ₹22 crore (~32%) - PAT increased by ₹11 crore (~92%) - Operating margin improved by ~4.9 percentage points - Margin Outlook: - The presentation does not explicitly state any forward-looking or target margin outlook.
From Omaxe Ltd's Q2 FY17 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q2 FY17 vs Q2 FY16 Sales/Volume:
- Area Sold: 0.79 mn sq.ft (Q2 FY17) vs 1.24 mn sq.ft (Q2 FY16), down 36%
- Value of Booking: Rs. 218 Cr (Q2 FY17) vs Rs. 401 Cr (Q2 FY16), down 46%
- Average Rate per sq.ft: Rs. 2756 (Q2 FY17) vs Rs. 3237 (Q2 FY16), down 15%
- Income from Operation: Rs. 327 Cr (Q2 FY17) vs Rs. 301 Cr (Q2 FY16), up 8.6%
- EBITDA: Rs. 90 Cr (Q2 FY17) vs Rs. 68 Cr (Q2 FY16), up 32%
- PAT: Rs. 23 Cr (Q2 FY17) vs Rs. 12 Cr (Q2 FY16), up 92%
- Year-on-Year Half Year (H1 FY17 vs H1 FY16):
- Area Sold: 1.82 mn sq.ft (H1 FY17) vs 2.78 mn sq.ft (H1 FY16), down 35%
- Value of Booking: Rs. 510 Cr (H1 FY17) vs Rs. 1059 Cr (H1 FY16), down 52%
- Average Rate per sq.ft: Rs. 2806 (H1 FY17) vs Rs. 3813 (H1 FY16), down 26%
- Income from Operation: Rs. 764 Cr (H1 FY17) vs Rs. 611 Cr (H1 FY16)
- EBITDA: Rs. 204 Cr (H1 FY17) vs Rs. 140 Cr (H1 FY16)
- PAT: Rs. 68 Cr (H1 FY17) vs Rs. 30 Cr (H1 FY16)
2 more points management made on revenue & sales performance
Profitability & Margins
See what Omaxe Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Realty
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Omaxe Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Omaxe Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹349 Cr, net loss ₹191 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Omaxe Ltd's management said in earlier quarters
Frequently Asked Questions
What were Omaxe Ltd Q2 FY17 results?
Q2 FY17 vs Q2 FY16 Sales/Volume: - Area Sold: 0.79 mn sq.ft (Q2 FY17) vs 1.24 mn sq.ft (Q2 FY16), down 36% - Value of Booking: Rs. Q2 FY17 Financials vs Q2 FY16: - EBITDA: ₹90 crore (up from ₹68 crore) - PAT: ₹23 crore (up from ₹12 crore) - Operating (EBITDA) margin = EBITDA / Turnover = 90 / 327 ≈ 27.5% (Q2 FY16 margin = 68 / 301 ≈ 22.6%) - Year-on-Year Change: - EBITDA increased by ₹22 crore (~32%) - PAT increased by ₹11 crore (~92%) - Operating margin improved by ~4.9 percentage points - Margin Outlook: - The presentation does not explicitly state any forward-looking or target margin outlook.
What is Omaxe Ltd share price analysis?
Omaxe Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹2,146 Cr. Investors should review the full earnings analysis for detailed insights.
Is Omaxe Ltd planning capital expenditure?
The provided investor presentation of Omaxe Limited does not explicitly mention any capex, capacity expansion, or details about new plants or projects including amounts, status, or timelines.
Keep Omaxe Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
